Glaukos Corp (GKOS)
138.31
-0.13
(-0.09%)
USD |
NYSE |
Nov 18, 13:43
Glaukos Enterprise Value: 7.428B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 7.428B |
| November 14, 2024 | 7.437B |
| November 13, 2024 | 7.693B |
| November 12, 2024 | 7.714B |
| November 11, 2024 | 7.681B |
| November 08, 2024 | 7.610B |
| November 07, 2024 | 7.477B |
| November 06, 2024 | 7.549B |
| November 05, 2024 | 6.844B |
| November 04, 2024 | 7.038B |
| November 01, 2024 | 7.060B |
| October 31, 2024 | 7.086B |
| October 30, 2024 | 7.435B |
| October 29, 2024 | 7.383B |
| October 28, 2024 | 7.181B |
| October 25, 2024 | 6.989B |
| October 24, 2024 | 6.982B |
| October 23, 2024 | 6.953B |
| October 22, 2024 | 7.049B |
| October 21, 2024 | 7.091B |
| October 18, 2024 | 7.142B |
| October 17, 2024 | 6.915B |
| October 16, 2024 | 6.857B |
| October 15, 2024 | 6.825B |
| October 14, 2024 | 6.959B |
| Date | Value |
|---|---|
| October 11, 2024 | 6.786B |
| October 10, 2024 | 6.860B |
| October 09, 2024 | 6.933B |
| October 08, 2024 | 6.916B |
| October 07, 2024 | 6.759B |
| October 04, 2024 | 7.010B |
| October 03, 2024 | 6.780B |
| October 02, 2024 | 6.872B |
| October 01, 2024 | 6.766B |
| September 30, 2024 | 6.972B |
| September 27, 2024 | 6.845B |
| September 26, 2024 | 6.800B |
| September 25, 2024 | 6.735B |
| September 24, 2024 | 6.813B |
| September 23, 2024 | 6.828B |
| September 20, 2024 | 6.817B |
| September 19, 2024 | 6.942B |
| September 18, 2024 | 6.516B |
| September 17, 2024 | 6.476B |
| September 16, 2024 | 6.624B |
| September 13, 2024 | 6.734B |
| September 12, 2024 | 6.734B |
| September 11, 2024 | 6.691B |
| September 10, 2024 | 6.705B |
| September 09, 2024 | 6.906B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
942.81M
Minimum
Mar 20 2020
7.714B
Maximum
Nov 12 2024
3.109B
Average
2.516B
Median
Mar 22 2022
Enterprise Value Benchmarks
| Boston Scientific Corp | 136.84B |
| Baxter International Inc | 27.90B |
| Masimo Corp | 9.238B |
| Teleflex Inc | 10.44B |
| Perspective Therapeutics Inc | 240.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.41M |
| Revenue (Quarterly) | 96.67M |
| Total Expenses (Quarterly) | 121.33M |
| EPS Diluted (Quarterly) | -0.39 |
| Gross Profit Margin (Quarterly) | 76.64% |
| Profit Margin (Quarterly) | -22.15% |
| Earnings Yield | -2.14% |
| Normalized Earnings Yield | -1.953 |